Novocure (NVCR) Tops Q2 EPS by 9c

Novocure (NASDAQ: NVCR) reported Q2 EPS of ($0.31), $0.09 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $150.4 million versus the consensus estimate of $135.83 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• KeyCorp (KEY) files for 158.72M share offering by selling stockholders
• Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink